News and blogs
398 results found.
Blood Cancer UK research strategy - your questions answered
Read more about Blood Cancer UK's research strategy, find out how we will allocate funding, and how soon research should deliver impact for patients.
Catching Covid with blood cancer - Philip's story
Hear how Philip's family did everything they could to shelter him from Covid after he was diagnosed with Myelodysplasia (MDS), and how the vaccine offer enough protection.
I put my symptoms down to being pregnant, but it was actually blood cancer.
Read Jemma's story about how her Hodgkin lymphoma symptoms were mistaken as side effects of being pregnant.
The blood cancer jigsaw: how we start to piece together the bigger picture
Read more about Blood Cancer UK's article on the similarities between blood cancer treatments, and how some drugs and research are having an impact across multiple conditions.
Blood cancer clinical trials - Everything you didn't know you needed to know
Read Professor Andrew Pettitt's piece on blood cancer clinical trials, where he explains the benefits, concerns and availability of clinical trials to people with blood cancer..
How we're going to make sure everyone is included in our clinical trials
Discover how Blood Cancer UK recruits people to take part in their clinical trials.
My dad - the hero every story deserves
Read the Burke family's experience of non-Hodgkin lymphoma and why they're raising money for Blood Cancer UK in memory of their late father, Thomas.
David's fundraising story
Read about David's fundraising story.
Why am I being invited for a third COVID vaccine dose?
Read Blood Cancer UK's advice on why people with blood cancer are being invited for a third COVID vaccine dose.
Mila Sneddon Scoots in September to raise money for children with blood cancer
Mila Sneddon Scoots in September to raise money for children with blood cancer
Our research investment into acute myeloid leukaemia (AML)
Professor Brian Huntly discusses Blood Cancer UK's investment into research into acute myeloid leukaemia (AML)
Fears blood cancer cases are being missed, as more than half of Brits can't name blood cancer symptoms
Blood Cancer UK warns that more than half of people in Britain can't name the symptoms of blood cancer, the UK’s third biggest cancer killer.
How we helped Covid booster vaccine research
Discover how Blood Cancer UK played a key part in Covid booster vaccine research for immune compromised patients, helping to create the OCTAVE-DUO study.
Can a blood test detect cancer?
Learn more about a new blood test that looks at cell-free DNA (cfDNA) that could detect cancers earlier.
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
Find out why better treatments and vaccine efficacy should make people with blood cancer more hopeful about the Covid pandemic.
Open letter from cancer charities to the public
40 charities and organisations have written an open letter, urging the public to help keep vulnerable people safe as restrictions ease.
Leading clinicians ask Government to improve Covid support for people with blood cancer
Blood Cancer UK leads 37 clinicians in asking the UK Government to do more to protect people with blood cancer from coronavirus.
Vaccine Collaborative announce further funding for vaccine efficacy research
Find out more about the increased funding into Covid vaccine efficacy research by the Blood Cancer Vaccine Research Collaborative.
Why we've decided to push the NHS on vaccine effectiveness
Discover why Blood Cancer UK has called on the Government and NHS to communicate with every immunocompromised person to tell them that the Covid vaccine may not be as effective for them.
Covid vaccines may not work for 80% of people with blood cancer
Blood Cancer UK warns the Government and the NHS that 80% of people with blood cancer haven't been told that the Covid vaccines are less likely to protect them.
